In a piece she writes for Newsweek, Sharon Begley says NIH's Cancer Genome Atlas "may be fatally flawed." And the price tag for TCGA means that "the atlas threatens to suck up ever-dwindling resources." The article explores the concept of the project and quotes scientists who argue that the its potential gain doesn't come close to justifying its expense.
Hey, that's a cheery thought for cancer researchers. Now back to work.